A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

CompletedOBSERVATIONAL
Enrollment

574

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Schizophrenia
Trial Locations (43)

Unknown

Research Site, Pátrai

Research Site, Nafplion

Research Site, Tripoli

Research Site, Athens

Research Site, Dafni

Research Site, Drapetsona

Research Site, Exarcheia

Research Site, Glifada

Research Site, Ilioúpoli

Research Site, Ilissia

Research Site, Koridalos

Research Site, Marousi

Research Site, N. Makri

Research Site, P. Faliro

Research Site, Pangrati

Research Site, Peristeri

Research Site, Petroúpolis

Research Site, Piraeus

Research Site, Zografos

Research Site, Athens

Research Site, Koropí

Research Site, Néo Irákleio

Research Site, Chania

Research Site, Kos

Research Site, Corfu

Research Site, Agrinio

Research Site, Alexandroupoli

Research Site, Lamia

Research Site, Heraklio

Research Site, Véroia

Research Site, Ioannina

Research Site, Karditsa

Research Site, Kavala

Research Site, Larissa

Research Site, Volos

Research Site, Kalamata

Research Site, Giannitsá

Research Site, Rethymno

Research Site, Komotini

Research Site, Serres

Research Site, Thessaloniki

Research Site, Trikala

Research Site, Thebes

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY